BiotechTubeBiotechTube
Home/Ventyx Biosciences/Matthew Moore
MM

Matthew Moore

Chief Operating Officer

Ventyx Biosciences

Therapeutic Areas

Autoimmune DiseasesInflammatory DiseasesNeurodegenerative DiseasesCardiometabolic Diseases

Ventyx Biosciences Pipeline

DrugIndicationPhase
VTX2735Recurrent PericarditisPhase 2
VTX3232Neurodegenerative and Cardiometabolic Diseases (e.g., Parkinson's, Alzheimer's, ALS)Phase 2
TamuzimodInflammatory Bowel Disease (IBD)Phase 2
VTX958Inflammatory Bowel Disease (IBD)Phase 2

Leadership Team at Ventyx Biosciences

RM
Raju Mohan, PhD
Founder, Chief Executive Officer & Director
MS
Mark S. Forman, MD, PhD
Chief Medical Officer
View full Ventyx Biosciences profile